Growth Opportunity Small, focused niche in neonatal care with a patented cranial support technology aimed at preventing HAPUs and DP in newborns, presenting a clear entry point with NICUs and pediatric care networks as primary customers.

Funding & Validation Prior funding rounds totaling around 8.3M and a recent 1.3M funding event suggest investor appetite and potential credibility to secure pilots, trials, or broader hospital system engagements.

Key Partnerships Appointment of a Medical Director and a dedicated medical team signals readiness for clinical collaboration, potentially easing regulatory approvals, clinical studies, and adoption within NICUs.

Market Readiness DP prevalence in the US has risen significantly, creating a large addressable population within newborn care that aligns with hospital quality initiatives and caregiver education programs.

Strategic Selling Headquartered in San Antonio with a Delaware C corporation structure and a lean employee base; emphasize scalable manufacturing partnerships, pilot programs with regional NICUs, and integration with existing neonatal care workflows.